Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigation

Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigation

Abstract Background The low data publication rate for Food and Drug Administration (FDA)-approved drugs, and discrepancies between FDA-submitted versus published data, remain a concern. We investigated the publication statuses of sponsor-submitted clinical trials supporting recent anticancer drugs a...

Full description

Bibliographic Details
Main Authors: Kenji Omae, Yuki Kataoka, Yasushi Tsujimoto, Yusuke Tsutsumi, Yosuke Yamamoto, Shunichi Fukuhara, Toshi A. Furukawa
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Cancer
Subjects:
Anticancer drugs
Clinical trials
Drug approval
Immune checkpoint inhibitors
Publications
United states food and drug administration
Online Access:http://link.springer.com/article/10.1186/s12885-019-6232-x

Internet

http://link.springer.com/article/10.1186/s12885-019-6232-x

Similar Items